preliminary evidence exists only for osteoarthritis via intra-articular injection Quick Facts Overview & Origin AOD-9604 (Anti-Obesity Drug 9604) is a 16-amino acid peptide comprising the C-terminal fragment of human growth hormone (hGH), specifically residues 177-191 of the native hormone, with an additional tyrosine residue at the N-terminus
After receiving a B12 shot, avoid heavy lifting or intense physical activity for the first 24 hours to minimize soreness at the injection site
Conclusions Ultimately, the current maintenance dose of 1,000 mcg B12 every 3 months may confer long term harm, therefore it seems that once B12 levels are stabilised well within acceptable range, then the standard B12 intervention of 1000 mcg should be administered annually, and monitored with pre-injection annual testing of levels
How do you calculate 5-Amino-1MQ dosage after reconstitution
Reference: Neelakantan H, Vance V, Wetzel MD, Wang HY, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ (2018)
AOD-9604 completed Phase 2 clinical trials for obesity in 2004, demonstrating fat loss without hyperglycemia
